ResMed, In A Buy Zone, Stays Flat After Handily Beating Earnings Views

Blockhead

01-31

ResMed (RMD) stock traded sideways late Thursday after the medtech company reported adjusted earnings of $2.43 per share on $1.28 billion in fiscal second-quarter sales.

↑ X NOW PLAYING How To Buy Stocks: Double-Bottom Chart Pattern

Analysts polled by FactSet expected the CPAP maker to earn $2.32 per share and $1.27 billion in sales. Sales increased 10%, while earnings rose more than 29%.

ResMed didn't provide guidance for the year. The Street projected EPS of $9.41 and $5.12 billion in sales.

In after-hours trades, ResMed stock was roughly flat at 257.65. Shares broke out of a double-bottom base with a buy point at 252.36, according to MarketSurge.

More to follow.

YOU MAY ALSO LIKE:

Thermo Fisher Scientific Gaps Up And Nears A Buy Point On Strong Earnings Beat

Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

Follow Premarket And After-The-Open Action With IBD Experts

Find Today's Best Growth Stocks To Watch With IBD 50

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2507605587"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2507605587\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2507605587?lang=zh_TW&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2024/04/Stock-Resmed-bldg-shutt-150x150.jpg","is_english":true,"pubTime":"2025-01-31 05:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2507605587","market":"fut","top_or_hot":-1,"title":"ResMed, In A Buy Zone, Stays Flat After Handily Beating Earnings Views","media":"Blockhead","content":"<html><body><div>\n<p><strong>ResMed</strong> (RMD) stock traded sideways late Thursday after the medtech company reported adjusted earnings of $2.43 per share on $1.28 billion in fiscal second-quarter sales.</p>\n<span>\n<span>\n<span jw-video-key=\"vULY99e2\" vid-authors=\"RACHEL FOX\" vid-cat=\"Investor's Corner\" vid-date=\"08/28/2024\" vid-date-tmsp=\"1724846001\" vid-dom-id=\"9354829-679bef6f8368a\" vid-id=\"9354829\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/08/vULY99e2-640x360.jpg\" vid-name=\"How To Buy Stocks: Double-Bottom Chart Pattern\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/vULY99e2.m3u8\" vid-width=\"100\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span>NOW PLAYING</span>\n<span>How To Buy Stocks: Double-Bottom Chart Pattern</span>\n</span>\n</span>\n</span>\n</span>\n<p>Analysts polled by FactSet expected the CPAP maker to earn $2.32 per share and $1.27 billion in sales. Sales increased 10%, while earnings rose more than 29%.</p>\n<p>ResMed didn't provide guidance for the year. The Street projected EPS of $9.41 and $5.12 billion in sales.</p>\n<p>In after-hours trades, ResMed stock was roughly flat at 257.65. Shares broke out of a double-bottom base with a buy point at 252.36, according to MarketSurge.</p>\n<p>More to follow.</p>\n<p><strong>YOU MAY ALSO LIKE:</strong></p>\n<p>Thermo Fisher Scientific Gaps Up And Nears A Buy Point On Strong Earnings Beat</p>\n<p>Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.</p>\n<p>Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks</p>\n<p>Follow Premarket And After-The-Open Action With IBD Experts</p>\n<p>Find Today's Best Growth Stocks To Watch With IBD 50</p>\n</div></body></html>","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ResMed, In A Buy Zone, Stays Flat After Handily Beating Earnings Views</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResMed, In A Buy Zone, Stays Flat After Handily Beating Earnings Views\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Blockhead</strong><span class=\"h-time small\">2025-01-31 05:14</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<p><strong>ResMed</strong> (RMD) stock traded sideways late Thursday after the medtech company reported adjusted earnings of $2.43 per share on $1.28 billion in fiscal second-quarter sales.</p>\n<span>\n<span>\n<span jw-video-key=\"vULY99e2\" vid-authors=\"RACHEL FOX\" vid-cat=\"Investor's Corner\" vid-date=\"08/28/2024\" vid-date-tmsp=\"1724846001\" vid-dom-id=\"9354829-679bef6f8368a\" vid-id=\"9354829\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/08/vULY99e2-640x360.jpg\" vid-name=\"How To Buy Stocks: Double-Bottom Chart Pattern\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/vULY99e2.m3u8\" vid-width=\"100\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span>NOW PLAYING</span>\n<span>How To Buy Stocks: Double-Bottom Chart Pattern</span>\n</span>\n</span>\n</span>\n</span>\n<p>Analysts polled by FactSet expected the CPAP maker to earn $2.32 per share and $1.27 billion in sales. Sales increased 10%, while earnings rose more than 29%.</p>\n<p>ResMed didn't provide guidance for the year. The Street projected EPS of $9.41 and $5.12 billion in sales.</p>\n<p>In after-hours trades, ResMed stock was roughly flat at 257.65. Shares broke out of a double-bottom base with a buy point at 252.36, according to MarketSurge.</p>\n<p>More to follow.</p>\n<p><strong>YOU MAY ALSO LIKE:</strong></p>\n<p>Thermo Fisher Scientific Gaps Up And Nears A Buy Point On Strong Earnings Beat</p>\n<p>Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.</p>\n<p>Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks</p>\n<p>Follow Premarket And After-The-Open Action With IBD Experts</p>\n<p>Find Today's Best Growth Stocks To Watch With IBD 50</p>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.investors.com/news/technology/resmed-stock-resmed-earnings-q2-2025/\">Blockhead</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMD","symbol_name":"瑞思邁","start_time":0,"source_url":"https://www.investors.com/news/technology/resmed-stock-resmed-earnings-q2-2025/","article_id":"2507605587","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/04/Stock-Resmed-bldg-shutt-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507605587","pubTimestamp":1738271677,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"ResMed stock was roughly flat late Thursday after the CPAP maker beat earnings expectations. Shares are in a buy zone.","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RMD":"瑞思迈"},"translate_title":"瑞思迈(ResMed)处于买入区域，在轻松超出盈利预期后保持持平","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":1},"content_text":"ResMed (RMD) stock traded sideways late Thursday after the medtech company reported adjusted earnings of $2.43 per share on $1.28 billion in fiscal second-quarter sales.\n\n\n\n↑\nX\n\nNOW PLAYING\nHow To Buy Stocks: Double-Bottom Chart Pattern\n\n\n\n\nAnalysts polled by FactSet expected the CPAP maker to earn $2.32 per share and $1.27 billion in sales. Sales increased 10%, while earnings rose more than 29%.\nResMed didn't provide guidance for the year. The Street projected EPS of $9.41 and $5.12 billion in sales.\nIn after-hours trades, ResMed stock was roughly flat at 257.65. Shares broke out of a double-bottom base with a buy point at 252.36, according to MarketSurge.\nMore to follow.\nYOU MAY ALSO LIKE:\nThermo Fisher Scientific Gaps Up And Nears A Buy Point On Strong Earnings Beat\nTeva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.\nStocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks\nFollow Premarket And After-The-Open Action With IBD Experts\nFind Today's Best Growth Stocks To Watch With IBD 50","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}